Nova Patents
ES2760263T3

Gene therapy for retinitis pigmentosa

Abstract

A rAAV particle comprising a nucleic acid encoding a miR-708 or comprising a nucleic acid encoding a miR-708 and a nucleic acid encoding rhodopsin.

Term

8.5 yearsto projected expiry

Projected expiry 20 March 2035, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

95 members in 37 offices

This recordMember, by publication datePriority claim27 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201461969027PUnited States of America–
201461969027United States of AmericaP
2015021896United States of AmericaW

Members95

Family members, oldest first
DocumentOfficeKind
CA2943185A1CanadaA1
WO2015143418A2World Intellectual Property Organization (WIPO)A2
UY36044AUruguayA
WO2015143418A3World Intellectual Property Organization (WIPO)A3
TW201622752ATaiwan Province of ChinaA
AR099837A1ArgentinaA1
SG11201607005UASingaporeA
PH12016501684A1PhilippinesA1
AU2015230942A1AustraliaA1
DOP2016000237ADominican RepublicA
KR20160127832ARepublic of KoreaA
IL247543A0IsraelA0
IL247543D0IsraelD0
PE20161252A1PeruA1
CR20160480ACosta RicaA
MX2016012201AMexicoA
EP3119437A2European Patent Office (EPO)A2
EA201691891A1Eurasian Patent Organization (EAPO)A1
CN106456660AChinaA
ECSP16083000AEcuadorA
JP2017509632AJapanA
CL2016002333A1ChileA1
US2017173183A1United States of AmericaA1
ZA201605924BSouth AfricaB
BR112016021017A2BrazilA2
MA39390A1MoroccoA1
SG10201808218YASingaporeA
US10383953B2United States of AmericaB2
EP3119437B1European Patent Office (EPO)B1
UA120050C2UkraineC2
DK3119437T3DenmarkT3
PT3119437TPortugalT
LT3119437TLithuaniaT
RS59634B1SerbiaB1
SI3119437T1SloveniaT1
US2020046851A1United States of AmericaA1
ES2742887T3SpainT3
HRP20192141T1CroatiaT1
SG10201912968WASingaporeA
JP6669664B2JapanB2
HUE046454T2HungaryT2
EP3628334A1European Patent Office (EPO)A1
JP2020059737AJapanA
PL3119437T3PolandT3
ES2760263T3This recordSpainT3
TW202021627ATaiwan Province of ChinaA
IL247543AIsraelA
IL247543BIsraelB
IL275918D0IsraelD0
TWI706789BTaiwan Province of ChinaB
MX2020010694AMexicoA
AU2015230942B2AustraliaB2
AU2021200988A1AustraliaA1
IL275918AIsraelA
IL275918BIsraelB
IL284741AIsraelA
IL284741D0IsraelD0
US11103598B2United States of AmericaB2
US2022054657A1United States of AmericaA1
JP7048563B2JapanB2
MA39390B2MoroccoB2
MY190726AMalaysiaA
NZ724622ANew ZealandA
CN106456660BChinaB
JP2022084810AJapanA
IL284741BIsraelB
TWI780401BTaiwan Province of ChinaB
CN115252823AChinaA
KR20230006039ARepublic of KoreaA
IL284741B2IsraelB2
PH12016501684B1PhilippinesB1
EP3628334B1European Patent Office (EPO)B1
FI3628334T3FinlandT3
LT3628334TLithuaniaT
PT3628334TPortugalT
DK3628334T3DenmarkT3
RS64611B1SerbiaB1
NZ762841ANew ZealandA
SI3628334T1SloveniaT1
PL3628334T3PolandT3
HRP20231077T1CroatiaT1
ES2957840T3SpainT3
HUE063460T2HungaryT2
EP4345165A2European Patent Office (EPO)A2
MY203654AMalaysiaA
AU2021200988B2AustraliaB2
JP7534348B2JapanB2
DK3628334T5DenmarkT5
EP4345165A3European Patent Office (EPO)A3
AU2024227776A1AustraliaA1
US12201698B2United States of AmericaB2
MX376190BMexicoB
CA2943185CCanadaC
CA3254798A1CanadaA1
KR20250172735ARepublic of KoreaA